Inventor · disambiguated record
Mei Yee Vanessa Ding
Also filed as: DING MEI · DING MEI YEE · DING MEI YEE VANESSA
5 granted patents·6 pending applications·8 citations·filing 2014–2025
71Inventor score
Top patents by PatentIndex Score
11 records- 0187US11236160B2Anti-CEACAM6 antibodies and methods of useSINGAPORE HEALTH SERV PTE LTD·Filed 2017·Granted Feb 1, 2022·4 cites·12 claims
- 0281US12227570B2Anti-CEACAM6 antibodies and methods of useSINGAPORE HEALTH SERV PTE LTD·Filed 2023·Granted Feb 18, 2025·0 cites·12 claims
- 0374US10287547B2Enrichment and characterization of human corneal endothelial cells (hCENC) with novel monoclonal antibodyAGENCY SCIENCE TECH & RES·Filed 2014·Granted May 14, 2019·4 cites·4 claims
- 0473US11820821B2Anti-CEACAM6 antibodies and methods of useSINGAPORE HEALTH SERV PTE LTD·Filed 2021·Granted Nov 21, 2023·0 cites·9 claims
- 0569US2025230236A1Anti-ceacam6 antibodies and methods of useSINGAPORE HEALTH SERV PTE LTD·Filed 2025·Application pending·0 cites
- 0652US2025277060A1Antigen binding molecules and methods thereof iAGENCY SCIENCE TECH & RES·Filed 2022·Application pending·0 cites
- 0752US2024132595A1Antigen binding molecules and methods thereof iiAGENCY SCIENCE TECH & RES·Filed 2022·Application pending·0 cites
- 0852US2024238433A1Anti-ceacam5/6 antigen-binding molecules and methods of treatment thereofAGENCY SCIENCE TECH & RES·Filed 2022·Application pending·0 cites
- 0951US2024018221A1Antigen binding molecules and uses thereofAGENCY SCIENCE TECH & RES·Filed 2021·Application pending·0 cites
- 1049US11306153B2Anti-AXL tyrosine kinase receptor antibodies and uses thereofAGENCY SCIENCE TECH & RES·Filed 2017·Granted Apr 19, 2022·0 cites·18 claims
- 1148US2023110203A1Therapeutic methods for the treatment of subjects with risk alelles in il33MEDIMMUNE LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mei Yee Vanessa Ding files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →